MAPK inhibitor shows promise in clinical trial for neuropathic pain

被引:11
|
作者
Katie Kingwell
机构
关键词
D O I
10.1038/nrneurol.2011.84
中图分类号
学科分类号
摘要
引用
收藏
页码:360 / 360
相关论文
共 50 条
  • [32] Oral magnesium treatment in patients with neuropathic pain: a randomized clinical trial
    Pickering, Gisele
    Morel, Veronique
    Simen, Estelle
    Cardot, Jean-Michel
    Moustafa, Fares
    Delage, Noemie
    Picard, Pascale
    Eschalier, Sylvie
    Boulliau, Sylvia
    Dubray, Claude
    MAGNESIUM RESEARCH, 2011, 24 (02) : 28 - 35
  • [33] The ERK/MAPK pathway, as a target for the treatment of neuropathic pain
    Ma, WY
    Quirion, R
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (04) : 699 - 713
  • [35] Plant-Chemical Shows Promise for Pain Relief
    Kuehn, Bridget
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (08): : 760 - 760
  • [36] Lidocaine patch 5% treats all neuropathic pain qualities: Results of a randomized clinical trial using the Neuropathic Pain Scale
    Galer, BS
    Jensen, MP
    Ma, T
    Davies, PS
    Rowbotham, MC
    NEUROLOGY, 2002, 58 (07) : A129 - A130
  • [37] The clinical picture of neuropathic pain
    Jensen, TS
    Gottrup, H
    Sindrup, SH
    Bach, FW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 429 (1-3) : 1 - 11
  • [38] CLINICAL MANAGEMENT OF NEUROPATHIC PAIN
    MUCKE, L
    MACIEWICZ, R
    NEUROLOGIC CLINICS, 1987, 5 (04) : 649 - 663
  • [40] Hepatitis A vaccine trial in Nicaraguan children shows promise
    Orellana, C
    LANCET INFECTIOUS DISEASES, 2003, 3 (10): : 605 - 605